• If you are wondering whether Select Medical Holdings at US$16.45 is still reasonably priced or already stretched, the valuation story is where things start to get interesting.
• The stock has been relatively steady in the short term, with returns of 0.1% over the last week and 0.5% over the last month, while the 11.0% year to date and 11.1% one year returns sit alongside a 16.0% three year return and a decline of 11.6% over five years.
• Recent coverage has focused less on short term headlines and more on how investors are reassessing the long term profile of healthcare providers like Select Medical Holdings. That context helps explain why price moves have been measured rather than abrupt, and why many investors are looking past short term noise to focus on what they are paying for each dollar of future cash flow.
• On Simply Wall St's valuation checks, Select Medical Holdings currently scores 3 out of 6. The rest of this article will unpack what that means through different valuation methods, and will save a more holistic way to think about value for the end.

Approach 1: Select Medical Holdings Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting future cash flows and then discounting them back to today’s value using a required return. It is essentially asking what all of those future dollars are worth in today’s terms.

For Select Medical Holdings, the DCF here uses a 2 Stage Free Cash Flow to Equity approach. The company’s last twelve months Free Cash Flow is about $140.9 million. Simply Wall St then projects annual Free Cash Flow out to 2035, starting at an estimated $118.3 million in 2026 and moving to $103.9 million in 2035, with analyst estimates only available for the early years and the later period extrapolated.

Discounting those projected cash flows back to today gives an estimated intrinsic value of $12.83 per share. Set against the current share price of $16.45, the model suggests the stock is about 28.2% above this estimate, which points to it trading at a premium to this DCF view of value.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Select Medical Holdings may be overvalued by 28.2%. Discover 44 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Select Medical Holdings Price vs Earnings

For profitable companies, the P/E ratio is a useful shorthand for how much you are paying for each dollar of current earnings. It links directly to what the business is generating today, which many investors find easier to relate to than long range cash flow forecasts.

What counts as a "normal" P/E depends on how fast earnings are expected to grow and how risky those earnings are. Higher expected growth or lower perceived risk can justify a higher multiple, while slower growth or higher risk usually point to a lower one.

Select Medical Holdings currently trades on a P/E of 15.68x. That sits below the Healthcare industry average of 23.17x and well below the peer average of 43.53x. Simply Wall St also calculates a proprietary “Fair Ratio” of 19.63x, which is an estimate of what P/E might make sense for this stock given its earnings profile, industry, profit margins, size and risk factors.

This Fair Ratio is more tailored than a simple comparison with peers or the broad industry, because it adjusts for company specific traits rather than assuming every stock should trade on the same multiple. Set against the current 15.68x P/E, the 19.63x Fair Ratio suggests Select Medical Holdings may be undervalued on this measure.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Select Medical Holdings Narrative

Earlier it was mentioned that there is an even better way to understand valuation. This is where Narratives come in, giving you a simple story that ties your view on Select Medical Holdings to specific revenue, earnings and margin assumptions, then into a Fair Value that you can compare with the current price.

On Simply Wall St's Community page, Narratives let you set out your own version of the story in numbers. Instead of only looking at a single P/E or DCF output, you connect your expectations about inpatient rehab growth, outpatient margins or reimbursement risk directly to a forecast and a Fair Value estimate.

Because these Narratives are updated when new information arrives, such as guidance for 2026 revenue between US$5.6b and US$5.8b or earnings per share in the US$1.22 to US$1.32 range, they give you a living view of what different investors think Select Medical Holdings is worth and why.

For example, one bullish Narrative currently points to a Fair Value around US$17.00, while a more cautious Narrative sits near US$14.00. Seeing that spread side by side with the latest share price can help you decide whether you feel closer to the optimistic or cautious story before taking any action.

Do you think there's more to the story for Select Medical Holdings? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.